These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36035736)

  • 21. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
    Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
    J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of Health Options In prevention of Cardiovascular Events for people with Atrial Fibrillation (CHOICE-AF): A pilot study.
    Lowres N; Redfern J; Freedman SB; Orchard J; Bennett AA; Briffa T; Bauman A; Neubeck L
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):39-46. PubMed ID: 25187121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.
    Dorian P; Jung W; Newman D; Paquette M; Wood K; Ayers GM; Camm J; Akhtar M; Luderitz B
    J Am Coll Cardiol; 2000 Oct; 36(4):1303-9. PubMed ID: 11028487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
    Groenveld HF; Crijns HJ; Van den Berg MP; Van Sonderen E; Alings AM; Tijssen JG; Hillege HL; Tuininga YS; Van Veldhuisen DJ; Ranchor AV; Van Gelder IC;
    J Am Coll Cardiol; 2011 Oct; 58(17):1795-803. PubMed ID: 21996393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
    Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
    Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
    Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
    JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factor management of atrial fibrillation using mHealth: The Atrial Fibrillation - Helping Address Care with Remote Technology (AF-HEART) Pilot Study.
    Mitrani LR; Goldenthal I; Leskowitz J; Wan EY; Dizon J; Saluja D; Creber RM; Turchioe MR; Sciacca RR; Garan H; Hickey KT; Korner J; Biviano AB
    Cardiovasc Digit Health J; 2022 Feb; 3(1):14-20. PubMed ID: 35265931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).
    Ikemura N; Spertus JA; Kimura T; Mahaffey K; Piccini JP; Inohara T; Ueda I; Tanimoto K; Suzuki M; Nakamura I; Akaishi M; Mitamura H; Fukuda K; Takatsuki S; Kohsaka S
    BMJ Open; 2019 Dec; 9(12):e032746. PubMed ID: 31857312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
    JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation.
    Osmancik P; Budera P; Talavera D; Herman D; Vesela J; Prochazkova R; Rizov V; Kacer P
    J Interv Card Electrophysiol; 2020 Apr; 57(3):435-442. PubMed ID: 31001766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument.
    Björkenheim A; Brandes A; Magnuson A; Chemnitz A; Edvardsson N; Poçi D
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom burden and treatment perception in patients with atrial fibrillation, with and without a family history of atrial fibrillation.
    Fujisawa T; Kimura T; Kohsaka S; Ikemura N; Katsumata Y; Miyama H; Nakajima K; Nishiyama T; Aizawa Y; Kanki H; Nagami K; Fukuda K; Takatsuki S
    Heart Vessels; 2021 Feb; 36(2):267-276. PubMed ID: 32902701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Procedure Outcomes and Quality-of-Life Improvement 12 Months Post-Cryoballoon Ablation in Persistent Atrial Fibrillation: Results From the Multicenter CRYO4PERSISTENT AF Trial.
    Boveda S; Metzner A; Nguyen DQ; Chun KRJ; Goehl K; Noelker G; Deharo JC; Andrikopoulos G; Dahme T; Lellouche N; Defaye P
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1440-1447. PubMed ID: 30466850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Dixon A; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    Heart Rhythm; 2011 Dec; 8(12):1847-52. PubMed ID: 21740879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation.
    Hendriks JM; Vrijhoef HJ; Crijns HJ; Brunner-La Rocca HP
    Europace; 2014 Apr; 16(4):491-9. PubMed ID: 24058179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a Multimodal Online Lifestyle Intervention for Depressive Symptoms and Quality of Life in Individuals With a History of Major Depressive Disorder.
    Abbott RD; Sherwin K; Klopf H; Mattingly HJ; Brogan K
    Cureus; 2020 Jul; 12(7):e9061. PubMed ID: 32656047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
    Abed HS; Wittert GA; Leong DP; Shirazi MG; Bahrami B; Middeldorp ME; Lorimer MF; Lau DH; Antic NA; Brooks AG; Abhayaratna WP; Kalman JM; Sanders P
    JAMA; 2013 Nov; 310(19):2050-60. PubMed ID: 24240932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Nielsen JC; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Pehrson SM; Englund A; Hartikainen J; Mortensen LS; Hansen PS;
    Heart; 2017 Mar; 103(5):368-376. PubMed ID: 27566295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.
    Ahmed S; Ranchor AV; Crijns HJ; Van Veldhuisen DJ; Van Gelder IC;
    Europace; 2010 Jun; 12(6):785-91. PubMed ID: 20200016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.